342 related articles for article (PubMed ID: 11772961)
1. Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease.
Zhang Q; Lehmann A; Rigda R; Dent J; Holloway RH
Gut; 2002 Jan; 50(1):19-24. PubMed ID: 11772961
[TBL] [Abstract][Full Text] [Related]
2. Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects.
Lidums I; Lehmann A; Checklin H; Dent J; Holloway RH
Gastroenterology; 2000 Jan; 118(1):7-13. PubMed ID: 10611148
[TBL] [Abstract][Full Text] [Related]
3. The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease.
van Herwaarden MA; Samsom M; Rydholm H; Smout AJ
Aliment Pharmacol Ther; 2002 Sep; 16(9):1655-62. PubMed ID: 12197845
[TBL] [Abstract][Full Text] [Related]
4. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors.
Koek GH; Sifrim D; Lerut T; Janssens J; Tack J
Gut; 2003 Oct; 52(10):1397-402. PubMed ID: 12970129
[TBL] [Abstract][Full Text] [Related]
5. Effect of non-selective gamma-aminobutyric acid receptor stimulation on motor function of the lower oesophageal sphincter and gastro-oesophageal reflux in healthy human subjects.
Cantù P; Carmagnola S; Savojardo D; Allocca M; Penagini R
Aliment Pharmacol Ther; 2003 Oct; 18(7):699-704. PubMed ID: 14510743
[TBL] [Abstract][Full Text] [Related]
6. Effect of acute and chronic administration of the GABA B agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease.
Ciccaglione AF; Marzio L
Gut; 2003 Apr; 52(4):464-70. PubMed ID: 12631652
[TBL] [Abstract][Full Text] [Related]
7. The GABA(B) receptor agonist AZD9343 inhibits transient lower oesophageal sphincter relaxations and acid reflux in healthy volunteers: a phase I study.
Beaumont H; Smout A; Aanen M; Rydholm H; Lei A; Lehmann A; Ruth M; Boeckxstaens G
Aliment Pharmacol Ther; 2009 Nov; 30(9):937-46. PubMed ID: 19650825
[TBL] [Abstract][Full Text] [Related]
8. Effect of atropine on gastro-oesophageal reflux and transient lower oesophageal sphincter relaxations in patients with gastro-oesophageal reflux disease.
Lidums I; Checklin H; Mittal RK; Holloway RH
Gut; 1998 Jul; 43(1):12-6. PubMed ID: 9771399
[TBL] [Abstract][Full Text] [Related]
9. Transient lower oesophageal sphincter relaxations--a pharmacological target for gastro-oesophageal reflux disease?
Hirsch DP; Tytgat GN; Boeckxstaens GE
Aliment Pharmacol Ther; 2002 Jan; 16(1):17-26. PubMed ID: 11856074
[TBL] [Abstract][Full Text] [Related]
10. Gastroesophageal reflux disease and baclofen: is there a light at the end of the tunnel?
Wise J; Conklin JL
Curr Gastroenterol Rep; 2004 Jun; 6(3):213-9. PubMed ID: 15128488
[TBL] [Abstract][Full Text] [Related]
11. Reproducibility of meal-induced transient lower oesophageal sphincter relaxations in patients with gastro-oesophageal reflux disease.
Boeckxstaens GE; Hirsch DP; Verkleij CB; Lei A; Holman R; Lehmann A; Rydholm H
Neurogastroenterol Motil; 2005 Feb; 17(1):23-8. PubMed ID: 15670260
[TBL] [Abstract][Full Text] [Related]
12. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH.
Vela MF; Tutuian R; Katz PO; Castell DO
Aliment Pharmacol Ther; 2003 Jan; 17(2):243-51. PubMed ID: 12534409
[TBL] [Abstract][Full Text] [Related]
13. Progress with novel pharmacological strategies for gastro-oesophageal reflux disease.
Tonini M; De Giorgio R; De Ponti F
Drugs; 2004; 64(4):347-61. PubMed ID: 14969571
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of transient LES relaxations and reflux in ferrets by GABA receptor agonists.
Blackshaw LA; Staunton E; Lehmann A; Dent J
Am J Physiol; 1999 Oct; 277(4):G867-74. PubMed ID: 10516154
[TBL] [Abstract][Full Text] [Related]
15. Effects of baclofen on the functional anatomy of the oesophago-gastric junction and proximal stomach in healthy volunteers and patients with GERD assessed by magnetic resonance imaging and high-resolution manometry: a randomised controlled double-blind study.
Curcic J; Schwizer A; Kaufman E; Forras-Kaufman Z; Banerjee S; Roy S; Pal A; Hebbard GS; Boesiger P; Fried M; Steingoetter A; Schwizer W; Fox M
Aliment Pharmacol Ther; 2014 Nov; 40(10):1230-40. PubMed ID: 25230154
[TBL] [Abstract][Full Text] [Related]
16. Randomised clinical trial: the effect of baclofen in patients with gastro-oesophageal reflux--a randomised prospective study.
Cossentino MJ; Mann K; Armbruster SP; Lake JM; Maydonovitch C; Wong RK
Aliment Pharmacol Ther; 2012 May; 35(9):1036-44. PubMed ID: 22428773
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of baclofen on lower oesophageal sphincter pressure and proximal gastric motility in humans.
Lee KJ; Vos R; Janssens J; Tack J
Aliment Pharmacol Ther; 2003 Jul; 18(2):199-207. PubMed ID: 12869080
[TBL] [Abstract][Full Text] [Related]
18. Effects of repeated administration of baclofen on transient lower esophageal sphincter relaxation in the dog.
Lehmann A; Hansson-Brändén L; Kärrberg L
Eur J Pharmacol; 2000 Sep; 403(1-2):163-7. PubMed ID: 10969158
[TBL] [Abstract][Full Text] [Related]
19. Effect of baclofen on gastric acid pocket in subjects with gastroesophageal reflux disease symptoms.
Scarpellini E; Boecxstaens V; Broers C; Vos R; Pauwels A; Tack J
Dis Esophagus; 2016 Nov; 29(8):1054-1063. PubMed ID: 26541138
[TBL] [Abstract][Full Text] [Related]
20. Prolonged measurement of lower oesophageal sphincter function in patients with intestinal metaplasia at the oesophagogastric junction.
Wolf C; Timmer R; Breumelhof R; Seldenrijk CA; Smout AJ
Gut; 2001 Sep; 49(3):354-8. PubMed ID: 11511556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
